Refoxy Pharma is a pre-clinical stage biotechnology company developing medicines for the treatment and prevention of aging and aging-associated diseases.
Total raised: $9.57M
Funding Rounds 1
| Date | Series | Amount | Investors |
| 04.12.2024 | Seed | $9.57M | - |
Mentions in press and media 4
| Date | Title | Description |
| 05.12.2024 | Refoxy Pharmaceuticals Secures €9.1 Million to Tackle Idiopathic Pulmonary Fibrosis | In the bustling world of biotechnology, where innovation meets necessity, Refoxy Pharmaceuticals has emerged as a beacon of hope. The Berlin-based company recently announced a significant funding milestone, raising €9.1 million in a seed ex... |
| 04.12.2024 | Refoxy Pharmaceuticals Raises €9.1M in Seed Extension | Refoxy Pharmaceuticals, a Berlin, Germany-based preclinical biotech company developing small molecule activators of the FOXO3 transcription factor for the treatment of age-related diseases, raised €9.1M in Seed extension funding. The round ... |
| 04.12.2024 | Biotech Refoxy Pharmaceuticals advances research with €9.1M funding | Biotech Refoxy Pharmaceuticals has raised €9.1 million Seed-extension financing. The German startup is the first preclinical biotech company purposely developing small molecule activators of the FOXO3 transcription factor for the treatment ... |
| 04.12.2024 | Refoxy Pharmaceuticals raises €9.1 million to progress its novel FOXO3 therapeutics for Idiopathic Pulmonary Fibrosis | Investment led by Boehringer Ingelheim Venture Fund, with the participation of new & existing investors, including Apollo Health Ventures, NRW.Venture, & HTGF. COLOGNE, GERMANY, December 4, 2024 /EINPresswire.com/ -- Refoxy Pharmace... |